- BioReference Laboratories (BRLI +2%) acquires most of Hunter Laboratories' assets, giving BRLI a West Cost presence and Medi-Cal in-network status.
- "Having a local base for operations can provide significant operational and logistical synergies," CEO Marc Grodman notes. (PR)
- Shares of Neogenomics (NEO -7.8%), a notable peer, are off sharply on the session.
BioReference makes acquisition, establishes West Coast presence
Aug 13 2013, 15:15 ET